🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the mass balance recovery and metabolite profile, ...
Status
Completed
Location
Quotient Sciences
Start Date
2021-07-14
Trial ID
NCT04952467
Treatments Being Tested
This is a multicenter, Phase 2, double-blind, randomized, parallel-arm, pla...
Status
Completed
Location
Advanced Research Center
Start Date
2022-05-19
Trial ID
NCT05376150
Treatments Being Tested
X-CEED-OLE is a Phase 3, multicenter, open-label study to evaluate the long...
Status
Enrolling By Invitation
Location
Woodland International Research Group
Start Date
2025-10-30
Trial ID
NCT07217860
Treatments Being Tested
X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Noble Clinical Research
Start Date
2025-08-08
Trial ID
NCT07172516
Treatments Being Tested
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
IMA Clinical Research Phoenix
Start Date
2024-12-20
Trial ID
NCT06775379
Treatments Being Tested
X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
Harmonex Neuroscience Research
Start Date
2025-07-08
Trial ID
NCT07076407
Treatments Being Tested
This project is designed to examine the neuronal KCNQ2/3 potassium (K+) cha...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2021-10-19
Trial ID
NCT04827901
The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-c...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-01-30
Trial ID
NCT03796962
Treatments Being Tested
X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term saf...
Status
Enrolling By Invitation
Location
Ima Clinical Research - Phoenix
Start Date
2025-03-18
Trial ID
NCT06922110
Treatments Being Tested